Report Detail

Other Global Tonic-Clonic Seizures Market Size, Status and Forecast 2019-2025

  • RnM2744435
  • |
  • 12 July, 2019
  • |
  • Global
  • |
  • 97 Pages
  • |
  • QYResearch
  • |
  • Other

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Tonic-Clonic Seizures Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Barbiturates
      • 1.4.3 Hydantoin
      • 1.4.4 Phenyltriazine
      • 1.4.5 Iminostilbenes
      • 1.4.6 Benzodiazepines
      • 1.4.7 Aliphatic Carboxylic Acid
      • 1.4.8 Others
    • 1.5 Market by Application
      • 1.5.1 Global Tonic-Clonic Seizures Market Share by Application (2014-2025)
      • 1.5.2 Hospitals
      • 1.5.3 Clinics
      • 1.5.4 Academic and Research Centers
      • 1.5.5 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Tonic-Clonic Seizures Market Size
    • 2.2 Tonic-Clonic Seizures Growth Trends by Regions
      • 2.2.1 Tonic-Clonic Seizures Market Size by Regions (2014-2025)
      • 2.2.2 Tonic-Clonic Seizures Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Tonic-Clonic Seizures Market Size by Manufacturers
      • 3.1.1 Global Tonic-Clonic Seizures Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Tonic-Clonic Seizures Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Tonic-Clonic Seizures Market Concentration Ratio (CR5 and HHI)
    • 3.2 Tonic-Clonic Seizures Key Players Head office and Area Served
    • 3.3 Key Players Tonic-Clonic Seizures Product/Solution/Service
    • 3.4 Date of Enter into Tonic-Clonic Seizures Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Tonic-Clonic Seizures Market Size by Type (2014-2019)
    • 4.2 Global Tonic-Clonic Seizures Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Tonic-Clonic Seizures Market Size (2014-2019)
    • 5.2 Tonic-Clonic Seizures Key Players in United States
    • 5.3 United States Tonic-Clonic Seizures Market Size by Type
    • 5.4 United States Tonic-Clonic Seizures Market Size by Application

    6 Europe

    • 6.1 Europe Tonic-Clonic Seizures Market Size (2014-2019)
    • 6.2 Tonic-Clonic Seizures Key Players in Europe
    • 6.3 Europe Tonic-Clonic Seizures Market Size by Type
    • 6.4 Europe Tonic-Clonic Seizures Market Size by Application

    7 China

    • 7.1 China Tonic-Clonic Seizures Market Size (2014-2019)
    • 7.2 Tonic-Clonic Seizures Key Players in China
    • 7.3 China Tonic-Clonic Seizures Market Size by Type
    • 7.4 China Tonic-Clonic Seizures Market Size by Application

    8 Japan

    • 8.1 Japan Tonic-Clonic Seizures Market Size (2014-2019)
    • 8.2 Tonic-Clonic Seizures Key Players in Japan
    • 8.3 Japan Tonic-Clonic Seizures Market Size by Type
    • 8.4 Japan Tonic-Clonic Seizures Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Tonic-Clonic Seizures Market Size (2014-2019)
    • 9.2 Tonic-Clonic Seizures Key Players in Southeast Asia
    • 9.3 Southeast Asia Tonic-Clonic Seizures Market Size by Type
    • 9.4 Southeast Asia Tonic-Clonic Seizures Market Size by Application

    10 India

    • 10.1 India Tonic-Clonic Seizures Market Size (2014-2019)
    • 10.2 Tonic-Clonic Seizures Key Players in India
    • 10.3 India Tonic-Clonic Seizures Market Size by Type
    • 10.4 India Tonic-Clonic Seizures Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Tonic-Clonic Seizures Market Size (2014-2019)
    • 11.2 Tonic-Clonic Seizures Key Players in Central & South America
    • 11.3 Central & South America Tonic-Clonic Seizures Market Size by Type
    • 11.4 Central & South America Tonic-Clonic Seizures Market Size by Application

    12 International Players Profiles

    • 12.1 Pfizer
      • 12.1.1 Pfizer Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Tonic-Clonic Seizures Introduction
      • 12.1.4 Pfizer Revenue in Tonic-Clonic Seizures Business (2014-2019)
      • 12.1.5 Pfizer Recent Development
    • 12.2 Johnson & Johnson
      • 12.2.1 Johnson & Johnson Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Tonic-Clonic Seizures Introduction
      • 12.2.4 Johnson & Johnson Revenue in Tonic-Clonic Seizures Business (2014-2019)
      • 12.2.5 Johnson & Johnson Recent Development
    • 12.3 UCB Celltech
      • 12.3.1 UCB Celltech Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Tonic-Clonic Seizures Introduction
      • 12.3.4 UCB Celltech Revenue in Tonic-Clonic Seizures Business (2014-2019)
      • 12.3.5 UCB Celltech Recent Development
    • 12.4 Abbott Laboratories
      • 12.4.1 Abbott Laboratories Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Tonic-Clonic Seizures Introduction
      • 12.4.4 Abbott Laboratories Revenue in Tonic-Clonic Seizures Business (2014-2019)
      • 12.4.5 Abbott Laboratories Recent Development
    • 12.5 GlaxoSmithKline
      • 12.5.1 GlaxoSmithKline Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Tonic-Clonic Seizures Introduction
      • 12.5.4 GlaxoSmithKline Revenue in Tonic-Clonic Seizures Business (2014-2019)
      • 12.5.5 GlaxoSmithKline Recent Development
    • 12.6 Novartis
      • 12.6.1 Novartis Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Tonic-Clonic Seizures Introduction
      • 12.6.4 Novartis Revenue in Tonic-Clonic Seizures Business (2014-2019)
      • 12.6.5 Novartis Recent Development
    • 12.7 Sanofi
      • 12.7.1 Sanofi Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Tonic-Clonic Seizures Introduction
      • 12.7.4 Sanofi Revenue in Tonic-Clonic Seizures Business (2014-2019)
      • 12.7.5 Sanofi Recent Development
    • 12.8 Shire
      • 12.8.1 Shire Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Tonic-Clonic Seizures Introduction
      • 12.8.4 Shire Revenue in Tonic-Clonic Seizures Business (2014-2019)
      • 12.8.5 Shire Recent Development
    • 12.9 Teva Pharmaceutical
      • 12.9.1 Teva Pharmaceutical Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Tonic-Clonic Seizures Introduction
      • 12.9.4 Teva Pharmaceutical Revenue in Tonic-Clonic Seizures Business (2014-2019)
      • 12.9.5 Teva Pharmaceutical Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Epilepsy is a group of neurological disorders characterized by brief, involuntary episodes of vigorous shaking of a part or complete body. The patient may experience loss or disturbance of consciousness and movements along with sensory or psychiatric disturbances. Grand mal seizures or tonic–clonic seizures are a type of generalized seizures, which affect the entire brain and are the most common type of epileptic seizures. Grand mal seizures are caused by neurotransmitter imbalances, which can also be influenced by fatigue, lack of sleep, hypertension, stress, intense lighting, rapid motion, blood sugar level, anxiety, etc. The grand mal seizures consist of two phases, the tonic phase and the clonic phase. The tonic phase involves loss of consciousness and muscle twitching and the phase usually last only for a few seconds. The clonic phase consists of rapid muscle contraction and relaxation resulting in convulsions.
      The Americas accounts for the significant market share owing to extensive use of medications and greater expenditure on the health care. Additionally, the fastest uptake of new technology and drugs in the US drives the global grand mal seizures market. The concentration of the major medical diagnostic device manufacturers in the developed regions is also adding fuel to the market. Europe is the second largest market due to a high disposable income and rising awareness about the grand mal seizures.
      Asia Pacific region is expected to grow rapidly and China and India are likely to lead the market during the forecast period.
      In 2018, the global Tonic-Clonic Seizures market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Tonic-Clonic Seizures status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Tonic-Clonic Seizures development in United States, Europe and China.

      The key players covered in this study
      Pfizer
      Johnson & Johnson
      UCB Celltech
      Abbott Laboratories
      GlaxoSmithKline
      Novartis
      Sanofi
      Shire
      Teva Pharmaceutical

      Market segment by Type, the product can be split into
      Barbiturates
      Hydantoin
      Phenyltriazine
      Iminostilbenes
      Benzodiazepines
      Aliphatic Carboxylic Acid
      Others

      Market segment by Application, split into
      Hospitals
      Clinics
      Academic and Research Centers
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Tonic-Clonic Seizures status, future forecast, growth opportunity, key market and key players.
      To present the Tonic-Clonic Seizures development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Tonic-Clonic Seizures are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Tonic-Clonic Seizures . Industry analysis & Market Report on Tonic-Clonic Seizures is a syndicated market report, published as Global Tonic-Clonic Seizures Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Tonic-Clonic Seizures market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,014.93
      4,522.40
      6,029.86
      3,501.56
      5,252.35
      7,003.13
      423,423.00
      635,134.50
      846,846.00
      276,594.24
      414,891.36
      553,188.48
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report